|
| |

|
|
|
|
Nicotine, one of more than 4,000 chemicals found
in the smoke from tobacco products such as cigarettes, cigars, and pipes, is the primary
component in tobacco that acts on the brain. Smokeless tobacco products
such as snuff and chewing tobacco also contain many toxins as well as high levels of
nicotine. Nicotine, recognized as one of the most frequently used addictive drugs, is a
naturally occurring colorless liquid that turns brown when burned and acquires the odor of
tobacco when exposed to air. There are many species of tobacco plants; the tabacum species
serves as the major source of tobacco products today. Since nicotine was first identified
in the early 1800s, it has been studied extensively and shown to have a number of complex
and sometimes unpredictable effects on the brain and the body.
Cigarette smoking is the most prevalent form of nicotine addiction in the United
States. Most cigarettes in the U.S. market today contain 10 milligrams (mg) or more of
nicotine. Through inhaling smoke, the average smoker takes in 1 to 2 mg nicotine per
cigarette. There have been substantial increases in the sale and consumption of smokeless
tobacco products also, and more recently, in cigar sales.
Nicotine is absorbed through the skin and mucosal lining of the mouth and nose or by
inhalation in the lungs. Depending on how tobacco is taken, nicotine can reach peak levels
in the bloodstream and brain rapidly. Cigarette smoking, for example, results in rapid
distribution of nicotine throughout the body, reaching the brain within 10 seconds of
inhalation. Cigar and pipe smokers, on the other hand, typically do not inhale the smoke,
so nicotine is absorbed more slowly through the mucosal membranes of their mouths.
Nicotine from smokeless tobacco also is absorbed through the mucosal membranes. |
|
Yes, nicotine is addictive. Most smokers use
tobacco regularly because they are addicted to nicotine. Addiction is characterized by
compulsive drug-seeking and use, even in the face of negative health consequences, and
tobacco use certainly fits the description. It is well documented that most smokers
identify tobacco as harmful and express a desire to reduce or stop using it, and nearly 35
million of them make a serious attempt to quit each year. Unfortunately, less than 7
percent of those who try to quit on their own achieve more than 1 year of abstinence; most
relapse within a few days of attempting to quit.
Other factors to consider besides nicotine's addictive properties include its high
level of availability, the small number of legal and social consequences of tobacco use,
and the sophisticated marketing and advertising methods used by tobacco companies. These
factors, combined with nicotine's addictive properties, often serve as determinants for
first use and, ultimately, addiction.
Recent research has shown in fine detail how nicotine acts on the brain to produce a
number of behavioral effects. Of primary importance to its addictive nature are findings
that nicotine activates the brain circuitry that regulates feelings of pleasure, the
so-called reward pathways. A key brain chemical involved in mediating the desire to
consume drugs is the neurotransmitter dopamine, and research has shown that nicotine
increases the levels of dopamine in the reward circuits. Nicotine's pharmacokinetic
properties have been found also to enhance its abuse potential. Cigarette smoking produces
a rapid distribution of nicotine to the brain, with drug levels peaking within 10 seconds
of inhalation. The acute effects of nicotine dissipate in a few minutes, causing the
smoker to continue dosing frequently throughout the day to maintain the drug's pleasurable
effects and prevent withdrawal.
What people frequently do not realize is that the cigarette is a very efficient and
highly engineered drug-delivery system. By inhaling, the smoker can get nicotine to the
brain very rapidly with every puff. A typical smoker will take 10 puffs on a cigarette
over a period of 5 minutes that the cigarette is lit. Thus, a person who smokes about
1-1/2 packs (30 cigarettes) daily, gets 300 "hits" of nicotine to the brain each
day. These factors contribute considerably to nicotine's highly addictive nature.
Scientific research is also beginning to show that nicotine may not be the only
psychoactive ingredient in tobacco. Using advanced neuroimaging technology, scientists can
see the dramatic effect of cigarette smoking on the brain and are finding a marked
decrease in the levels of monoamineoxidase (MAO), an important enzyme that is responsible
for breaking down dopamine. The change in MAO must be caused by some tobacco smoke
ingredient other than nicotine, since we know that nicotine itself does not dramatically
alter MAO levels. The decrease in two forms of MAO, A and B, then results in higher
dopamine levels and may be another reason that smokers continue to smoke - to sustain the
high dopamine levels that result in the desire for repeated drug use. |
|
Nicotine can act as both a stimulant and a
sedative. Immediately after exposure to nicotine, there is a "kick" caused in
part by the drug's stimulation of the adrenal glands and resulting discharge of
epinephrine (adrenaline). The rush of adrenaline stimulates the body and causes a sudden
release of glucose as well as an increase in blood pressure, respiration, and heart rate.
Nicotine also suppresses insulin output from the pancreas, which means that smokers are
always slightly hyperglycemic. In addition, nicotine indirectly causes a release of
dopamine in the brain regions that control pleasure and motivation. This reaction is
similar to that seen with other drugs of abuse - such as cocaine and heroin - and it is
thought to underlie the pleasurable sensations experienced by many smokers. In contrast,
nicotine can also exert a sedative effect, depending on the level of the smoker's nervous
system arousal and the dose of nicotine taken. |
|
Chronic exposure to nicotine results in
addiction. Research is just beginning to document all of the neurological changes that
accompany the development and maintenance of nicotine addiction. The behavioral
consequences of these changes are well documented, however. Greater than 90 percent of
those smokers who try to quit without seeking treatment fail, with most relapsing within a
week.
Repeated exposure to nicotine results in the development of tolerance, the condition in
which higher doses of a drug are required to produce the same initial stimulation.
Nicotine is metabolized fairly rapidly, disappearing from the body in a few hours.
Therefore some tolerance is lost overnight, and smokers often report that the first
cigarettes of the day are the strongest and/or the "best." As the day
progresses, acute tolerance develops, and later cigarettes have less effect.
Cessation of nicotine use is followed by a withdrawal syndrome that may last a month or
more; it includes symptoms that can quickly drive people back to tobacco use. Nicotine
withdrawal symptoms include irritability, craving, cognitive and attentional deficits,
sleep disturbances, and increased appetite and may begin within a few hours after the last
cigarette. Symptoms peak within the first few days and may subside within a few weeks. For
some people, however, symptoms may persist for months or longer.
An important but poorly understood component of the nicotine withdrawal syndrome is
craving, an urge for nicotine that has been described as a major obstacle to successful
abstinence. High levels of craving for tobacco may persist for 6 months or longer. While
the withdrawal syndrome is related to the pharmacological effects of nicotine, many
behavioral factors also can affect the severity of withdrawal symptoms. For some people,
the feel, smell, and sight of a cigarette and the ritual of obtaining, handling, lighting,
and smoking the cigarette are all associated with the pleasurable effects of smoking and
can make withdrawal or craving worse. While nicotine gum and patches may alleviate the
pharmacological aspects of withdrawal, cravings often persist. |
|
The medical consequences of nicotine exposure
result from effects of both the nicotine itself and how it is taken. The most deleterious
effects of nicotine addiction are the result of tobacco use, which accounts for one-third
of all cancers. Foremost among the cancers caused by tobacco is lung cancer - the number
one cancer killer of both men and women. Cigarette smoking has been linked to about 90
percent of all lung cancer cases.
In addition to lung cancer, smoking also causes lung diseases such as chronic
bronchitis and emphysema, and it has been found to exacerbate asthma symptoms in adults
and children. Smoking is also associated with cancers of the mouth, pharynx, larynx,
esophagus, stomach, pancreas, cervix, kidney, ureter, and bladder. The overall rates of
death from cancer are twice as high among smokers as among nonsmokers, with heavy smokers
having rates that are four times greater than those of nonsmokers. Cigarette smoking is
the most important preventable cause of cancer in the United States.
In addition to its ability to cause cancer, a relationship between cigarette smoking
and coronary heart disease was first reported in the 1940s. Since that time, it has been
well documented that smoking substantially increases the risk of heart disease, including
stroke, heart attack, vascular disease, and aneurysm. It is estimated that nearly
one-fifth of deaths from heart disease are attributable to smoking.
While we often think of medical consequences that result from direct use of tobacco
products, passive or secondary smoke also increases the risk for many diseases.
Environmental tobacco smoke (ETS) is a major source of indoor air contaminants; secondhand
smoke is estimated to cause approximately 3,000 lung cancer deaths per year among
nonsmokers and contributes to as many as 40,000 deaths related to cardiovascular disease.
Exposure to tobacco smoke in the home increases the severity of asthma for children and is
a risk factor for new cases of childhood asthma. ETS exposure has been linked also with
sudden infant death syndrome. Additionally, dropped cigarettes are the leading cause of
residential fire fatalities, leading to more than 1,000 such deaths each year. At higher
doses, such as the nicotine that can be found in some insecticide sprays, nicotine can be
extremely toxic, causing vomiting, tremors, convulsions, and death. Nicotine poisoning has
been reported from accidental ingestion of insecticides by adults and ingestion of tobacco
products by children and pets. Death usually results in a few minutes from respiratory
failure caused by paralysis.
Laboratory research indicates that cigarette smoking causes toxic cardiovascular
effects. For this reason, nicotine replacement medicines such as nicotine gum and the
patch have been extensively evaluated for cardiovascular toxicity, especially for patients
with cardiac disease. These trials suggest that use of nicotine replacements for smoking
cessation does not increase cardiovascular risk. These findings are consistent with the
generally slower and lower doses of nicotine obtained from the medicines as compared to
tobacco products, and to the absence of carbon monoxide and numerous other toxins in
tobacco smoke. |
|
In pregnant women, carbon monoxide (a lethal
gas) and the high doses of nicotine obtained when they inhale tobacco smoke interferes
with oxygen supply to the fetus. Nicotine readily crosses the placenta, and nicotine
concentrations in the fetus can be as much as 15 percent higher than maternal levels. It
appears that nicotine is concentrated in fetal blood, amniotic fluid, and breast milk.
Another ingredient of tobacco smoke, carbon monoxide, has been shown to inhibit the
release of oxygen into fetal tissues. These factors, combined, likely account for the
developmental delays commonly seen in the fetuses and infants of smoking mothers.
Women who smoke during pregnancy are at greater risk than nonsmokers for premature
delivery, and there is a risk of lower birth weight for infants carried to term. In the
United States it is estimated that 20 percent or more of pregnant women smoke throughout
their pregnancies. The adverse effects of smoking may occur in every trimester of
pregnancy; they range from spontaneous abortions in the first trimester to increased
premature delivery rates and decreased birth weights in the final trimester. The decreased
birth weights seen in infants of mothers who smoke reflects a dose-dependent relationship:
the more the woman smokes during pregnancy, the greater the reduction of infant birth
weight. Conversely, women who give up smoking early in pregnancy have infants of similar
weight to those of nonsmokers. |
| source: NIDA Research Report - Nicotine Addiction: NIH
Publication No. 98-4342 |
Continued....
Top
of Page Home |
|